Advertisement
YOU ARE HERE: LAT HomeCollectionsStatdlander Drug Co
IN THE NEWS

Statdlander Drug Co

FEATURED ARTICLES
BUSINESS
November 10, 1998 | BARBARA MARSH, TIMES STAFF WRITER
Bergen Brunswig Corp., underscoring plans to expand its fast-growing specialty drug business, said Monday that it will pay $300 million for a Pennsylvania company that specializes in immune system medications. The Orange-based drug wholesaler said it will pay about $150 million in cash and $150 million in stock to buy Stadtlander Drug Co. of Pittsburgh from its parent, Counsel Corp. of Toronto.
ARTICLES BY DATE
BUSINESS
November 10, 1998 | BARBARA MARSH, TIMES STAFF WRITER
Bergen Brunswig Corp., underscoring plans to expand its fast-growing specialty drug business, said Monday that it will pay $300 million for a Pennsylvania company that specializes in immune system medications. The Orange-based drug wholesaler said it will pay about $150 million in cash and $150 million in stock to buy Stadtlander Drug Co. of Pittsburgh from its parent, Counsel Corp. of Toronto.
Los Angeles Times Articles
|